Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women

Diabetologia

Volumn 57, Issue 1, 2014, Pages 93-101

  Ley, Sylvia H ^a   Sun, Qi ^a,b   Jimenez, Monik C ^b   Rexrode, Kathryn M ^b   Manson, Joann E ^a,b   Jensen, Majken K ^a   Rimm, Eric B ^a,b   Hu, Frank B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Alcohol; Fetuin A; Insulin sensitivity; Type 2 diabetes

Indexed keywords

ALCOHOL; FETUIN A; INSULIN;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADULT; ALCOHOL DRINKING; ALPHA-2-HS-GLYCOPROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MIDDLE AGED;

EID: 84890955581     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3077-8     Document Type: Article

References (38)

1. Baliunas DO, Taylor BJ, Irving H et al (2009) Alcohol as a risk factor for type 2 diabetes. Diabetes Care 32:2123-2132
2. Koppes LL, Dekker JM, Hendriks HF, Bouter LM, Heine RJ (2005) Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 28:719-725
3. Liangpunsakul S, Chalasani N (2012) What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol 107:976-978
4. Bonnet F, Disse E, Laville M et al (2012) Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 55:3228-3237
5. Sierksma A, Patel H, Ouchi N et al (2004) Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 27:184-189
6. Thamer C, Haap M, Fritsche A, Haering H, Stumvoll M (2004) Relationship between moderate alcohol consumption and adiponectin and insulin sensitivity in a large heterogeneous population. Diabetes Care 27:1240
7. Sun Q, Cornelis MC, Manson JE, Hu FB (2013) Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes 62:49-55
8. Ix JH, Wassel CL, Kanaya AM et al (2008) Fetuin-a and incident diabetes mellitus in older persons. JAMA 300:182-188
9. Ix JH, Biggs ML, Mukamal KJ et al (2012) Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study. Circulation 125:2316-2322
10. Stefan N, Fritsche A, Weikert C et al (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57:2762-2767
11. Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH (2013) The sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo Study. Diabetes Care 36:1994-2000
12. Rasul S, Wagner L, Kautzky-Willer A (2012) Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus. Endocrine 42:496-505
13. Goustin A-S, Abou-Samra AB (2011) The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor: insights into the mechanism of insulin resistance. Cell Signal 23:980-990
14. Auberger P, Falquerho L, Contreres JO et al (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58:631-640
15. Srinivas PR, Wagner AS, Reddy LV et al (1993) Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 7:1445-1455
16. Hennige AM, Staiger H, Wicke C et al (2008) Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS ONE 3:e1765
17. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792
18. Prentice RL, Breslow NE (1978) Retrospective studies and failure time models. Biometrika 65(1):153-158
19. Willett WC, Sampson L, Stampfer MJ et al (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51-65
20. Willett W (1998) Nutritional epidemiology. Oxford University Press, New York
21. Fuchs CS, Stampfer MJ, Colditz GA et al (1995) Alcohol consumption and mortality among women. N Engl J Med 332:1245-1250
22. Giovannucci E, Colditz G, Stampfer MJ et al (1991) The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 133:810-817
23. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE (1987) Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316:1174-1180
24. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1:466-473
25. Colditz GA, Martin P, Stampfer MJ et al (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123:894-900
26. Manson JE, Stampfer MJ, Colditz GA et al (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338:774-778
27. McCullough ML, Feskanich D, Stampfer MJ et al (2002) Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76:1261-1271
28. Rosner B, Cook N, Portman R, Daniels S, Falkner B (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167:653-666
29. Lin DY, Fleming TR, de Gruttola V (1997) Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med 16:1515-1527
30. Dunn W, Xu R, Schwimmer JB (2008) Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 47:1947-1954
31. Gunji T, Matsuhashi N, Sato H et al (2009) Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol 104:2189-2195
32. Moriya A, Iwasaki Y, Ohguchi S et al (2011) Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Aliment Pharmacol Ther 33:378-388
33. Englund Ögge L, Brohall G, Behre CJ, Schmidt C, Fagerberg B (2006) Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care 29:908-913
34. Joosten MM, Witkamp RF, Hendriks HFJ (2011) Alterations in total and high-molecular-weight adiponectin after 3 weeks of moderate alcohol consumption in premenopausal women. Metabolism 60:1058-1063
35. Beulens JWJ, Rimm EB, Hu FB, Hendriks HFJ, Mukamal KJ (2008) Alcohol consumption, mediating biomarkers, and risk of type 2 diabetes among middle-aged women. Diabetes Care 31:2050-2055
36. Nielsen SJ, Kit BK, Fakhouri T, Ogden CL (2012) Calories consumed from alcoholic beverages by U.S. adults, 2007-2010. NCHS Data Brief 110:1-8
37. Chrostek L, Jelski W, Szmitkowski M, Puchalski Z (2003) Gender-related differences in hepatic activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in humans. J Clin Lab Anal 17:93-96
38. Kotsopoulos J, Tworoger SS, Campos H et al (2010) Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 19:938-946